WORK Medical CEO Wu Shuang Jarod files Form 3

WORK Medical Technology Group LTD director and CEO Wu Shuang Jarod has filed an initial Form 3, which is a statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

WORK Medical Technology Group LTD director and CEO Wu Shuang Jarod has filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing does not list any stock transactions or holdings details and simply establishes him as a reporting insider for WOK.

Key Terms

Form 3, reporting persons, CEO and Director

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): initial insider ownership statement"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting persons regulatory

""reportingPersons": [{ "name": "Wu Shuang Jarod""

CEO and Director financial

""officer_title": "CEO and Director""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the WORK Medical (WOK) Form 3 filing by Wu Shuang Jarod mean?

The Form 3 filing shows that Wu Shuang Jarod, CEO and director of WORK Medical Technology Group LTD, has become a reporting insider. It is an initial beneficial ownership statement and, in this case, does not disclose any specific stock transactions.

Did Wu Shuang Jarod buy or sell any WOK shares in this Form 3?

No transactions are reported in this Form 3. The transaction summary shows zero buys, zero sells, and zero derivative exercises, indicating the filing is purely administrative to establish insider reporting status without recording trades.

What role does Wu Shuang Jarod hold at WORK Medical Technology Group LTD (WOK)?

Wu Shuang Jarod is identified as both CEO and director of WORK Medical Technology Group LTD. This dual role makes him a key executive and board member, which is why he is required to file insider ownership reports with the SEC.

Does this WOK Form 3 show any derivative securities or options for Wu Shuang Jarod?

The derivative summary in this Form 3 is empty, and the transaction summary shows zero derivative transactions or exercises. This means the filing excerpt does not list any options, warrants, or other derivative holdings for Wu Shuang Jarod.

Is Wu Shuang Jarod reported as a 10% owner of WORK Medical (WOK)?

The Form 3 data indicates that Wu Shuang Jarod is not classified as a ten percent owner. He is listed as a director and officer (CEO and director), but the ten percent owner flag is set to zero in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 11:32 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wu Shuang Jarod

(Last) (First) (Middle)

23/F, HUIYU BUILDING, TONGHUI SOUTH ROAD

XIAOSHAN DISTRICT

(Street)

HANGZHOU CITY ZHEJIANG PROVINCE 311202

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Director

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Shuang Wu	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)